Timeline:
ss
* 2020/02/01: Robust SKAT analysis to [Large cell lymphoma: 56 case vs 5544 control](extdata/Largecelllymphoma/)
* 2020/01/31: Robust SKAT analysis to [Cancer of urinary organs (incl. kidney and bladder): 421 case vs 41,679 control](extdata/urinarycancer/)
* 2020/01/30: Robust SKAT analysis to [Obesity: 1,192 case vs 44,381 control](extdata/obesity/)
* 2020/01/29: Robust SKAT analysis to [Type 2 Diabetes: 2,034 case vs 43,426 control](extdata/T2D/)
* 2020/01/28: Robust SKAT analysis to [Prostate cancer: 741 case vs 18,940 control](extdata/prostatecancer/)
* 2020/01/27: Robust SKAT analysis to [Lupus: 57 case vs 5,643 control](extdata/SLE/)
* 2020/01/26: Robust SKAT analysis to [Rheumatoid arthritis with  493 case and 41,022 control](extdata/RA/)
* 2020/01/25: Robust SKAT analysis to [Ankylosing spondylitis: 60 case and 5,940 control](extdata/AS/)
* 2020/01/25: Robust SKAT analysis to [Gout: 352 case and 34,848 control](extdata/Gout/)
* 2020/01/23: Robust SKAT analysis to [Osteoarthrosis with 3,014 cases and 42,572 controls](extdata/OA/)
* 2020/01/22: Robust SKAT analysis to [Rheumatoid arthritis and IPA with 582 cases and 41,021 control](extdata/RA-IPA/)
* 2020/01/21: upload [qqplot](./R/qqplot.R) function to RobustSKAT
* 2020/01/20: check the raw data with [ukb-50kexome.leelabsg](http://ukb-50kexome.leelabsg.org/pheno/695.4)
